Phase II clinical study of TY-0201 in patients with chronic heart failure

Trial Profile

Phase II clinical study of TY-0201 in patients with chronic heart failure

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs Bisoprolol (Primary)
  • Indications Chronic heart failure
  • Focus Therapeutic Use
  • Sponsors Toa Eiyo
  • Most Recent Events

    • 02 Aug 2017 Primary endpoint (The change in LVEF at 16 weeks after the treatment period compared with baseline.) has not been met as per results published in the Circulation Journal
    • 02 Aug 2017 Results published in the Circulation Journal
    • 14 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top